Skip to content

Savara SVRA Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$847K-82.6%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$259K+3.6%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$241K+1,105%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$2.2M-13.1%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$1.39M+253%
TRV
Trevi Therapeutics, Inc.TRVI
$222K-69.1%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+134%
Enterprise value$1.19B+127%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's stock issuance proceeds?
Savara (SVRA) reported stock issuance proceeds of $45K in Q1 2026.
How has Savara's stock issuance proceeds changed year-over-year?
Savara's stock issuance proceeds decreased by 72.7% year-over-year, from $165K to $45K.
What is the long-term trend for Savara's stock issuance proceeds?
Over 4 years (2021 to 2025), Savara's stock issuance proceeds has grown at a 115.8% compound annual growth rate (CAGR), from $16K to $347K.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.